Ann Mullally
@mullallylab.bsky.social
Heme Chief at Stanford. Physician Scientist studying myeloid malignancies. Views my own.
Reposted by Ann Mullally
Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together!
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
November 25, 2025 at 12:01 AM
Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together!
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Subscribe anywhere you listen to podcasts or watch on YouTube at https://bit.ly/44vtyMX
Reposted by Ann Mullally
The highly anticipated #ASH25 late-breaking abstracts have been posted: https://ow.ly/EGCi50XwYbf
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
November 24, 2025 at 5:01 PM
The highly anticipated #ASH25 late-breaking abstracts have been posted: https://ow.ly/EGCi50XwYbf
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
👏 #ASHKudos to the presenters!
Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky
This was an amazing MGR presentation!
@stanforddeptmed.bsky.social
@stanforddeptmed.bsky.social
Stanford Bioengineering's Mark Skylar-Scott shared his 3D bioprinting work at #StanDOM's Medicine Grand Rounds, creating vascularized heart tissues & scaling stem-cell-based organ fabrication to bring lab breakthroughs to clinical care.
November 24, 2025 at 6:18 PM
This was an amazing MGR presentation!
@stanforddeptmed.bsky.social
@stanforddeptmed.bsky.social
Now online in Cancer Discovery @aacrjournals.bsky.social: DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated with Increased LSC Frequency - by Thomas Köhnke, Daiki Karigane, Ravi Majeti, et al. doi.org/10.1158/2159... @stanfordmedicine.bsky.social
November 24, 2025 at 3:55 PM
Reposted by Ann Mullally
If you have not read this moving and courageous essay from Tatiana Schlossberg in the @newyorker.com, please check it out. You may be wondering why inv(3) leukemia is so deadly? Here is a brief 🧵 (1/n)
Tatiana Schlossberg, the daughter of Caroline Kennedy, had just given birth when she was diagnosed with a rare form of leukemia. She writes about her fear of adding another tragedy to her family’s life. https://newyorkermag.visitlink.me/CLpbsb
November 24, 2025 at 2:40 PM
If you have not read this moving and courageous essay from Tatiana Schlossberg in the @newyorker.com, please check it out. You may be wondering why inv(3) leukemia is so deadly? Here is a brief 🧵 (1/n)
Reposted by Ann Mullally
Tatiana Schlossberg, the daughter of Caroline Kennedy, had just given birth when she was diagnosed with a rare form of leukemia. She writes about her fear of adding another tragedy to her family’s life. https://newyorkermag.visitlink.me/CLpbsb
November 23, 2025 at 1:01 AM
Tatiana Schlossberg, the daughter of Caroline Kennedy, had just given birth when she was diagnosed with a rare form of leukemia. She writes about her fear of adding another tragedy to her family’s life. https://newyorkermag.visitlink.me/CLpbsb
Very cool! @stanforddeptmed.bsky.social
Something new is coming from #StanDOM on Dec. 1! Introducing The Future of Medicine, a new podcast built from the extraordinary speakers who join us for #StanDOMGrandRounds & hosted by our Chair, @euanashley.bsky.social. Subscribe on your favorite platforms at https://bit.ly/43LGRZv
November 22, 2025 at 12:42 AM
Very cool! @stanforddeptmed.bsky.social
Amazing! @ash.hematology.org
For 40+ years, the ASH Scholar Award has helped jumpstart careers in hematology—funding 678 awards, $82M in research, and $3B in follow-on funding. Learn more: https://bit.ly/4idJLvV
#ASHAwards
#ASHAwards
November 21, 2025 at 1:34 AM
Amazing! @ash.hematology.org
Delighted to welcome Dr. Fred Appelbaum from #FHCRC to Stanford #Hematology today! A giant in #bloodcancers, a superb #physicianscientist &
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social
November 13, 2025 at 4:32 PM
Delighted to welcome Dr. Fred Appelbaum from #FHCRC to Stanford #Hematology today! A giant in #bloodcancers, a superb #physicianscientist &
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social
Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social
From launching MGR 2.0 with inspiring guests to celebrating #WomenInMedicine, this past month reminded us that community connection is at the heart of everything we do. Check out #StanDOM's September highlights. 👇
October 15, 2025 at 2:49 AM
Fun times at #Stanford DOM, awesome community! @stanforddeptmed.bsky.social
Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis.
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
October 13, 2025 at 3:56 PM
Our own, Prof. Larry Leung is this month’s #Hematology Breakthroughs speaker! A former #Stanford Division Chief of Hematology, Larry’s lab studies the basic biology of thrombosis/hemostasis.
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
He will discuss all things #thrombin, promises to be a great seminar, Oct 16! 👇🏽
@stanforddeptmed.bsky.social
Reposted by Ann Mullally
If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!
November 27, 2024 at 10:54 PM
If you've been meaning to check out the Night Science Podcast, this is the perfect episode to get started with. Everyone is telling me it's our best one yet!
Very interesting, congrats! 🎊🎉
🚨 New paper alert!
Sex and smoking bias in the selection of somatic mutations in human bladder
www.nature.com/articles/s41...
by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
Sex and smoking bias in the selection of somatic mutations in human bladder
www.nature.com/articles/s41...
by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
Sex and smoking bias in the selection of somatic mutations in human bladder - Nature
Sex bias and association with smoking history identified in the landscape of driver mutations and clonal expansions in normal human bladder tissue may explain the higher bladder cancer risk in men and smokers.
www.nature.com
October 8, 2025 at 6:27 PM
Very interesting, congrats! 🎊🎉
Reposted by Ann Mullally
Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
October 7, 2025 at 3:46 PM
Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social
October 1, 2025 at 7:56 PM
Pretty awesome to have Nobel Laureate, Prof. Jennifer Doudna as our Medical Grand Rounds speaker today! #CRISPR @stanforddeptmed.bsky.social
Reposted by Ann Mullally
A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti
September 23, 2025 at 3:43 PM
A @stanfordmedicine.bsky.social clinical trial, led by #StanDOM's Jason Gotlib, results in FDA approval of a new treatment for a rare, deadly blood cancer. https://stan.md/4mXxtti
Enjoyed this interview!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
Geneticist Mary-Claire King has had a remarkable career. She changed how we understand hereditary cancer, helped reunite families after Argentina’s dictatorship, and upended conventional wisdom about our evolutionary origins.
buff.ly/nwsUeYu
buff.ly/nwsUeYu
September 21, 2025 at 11:42 PM
Enjoyed this interview!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
One of several takeaways: Constructive scientific criticism is a form of respect i.e. indicates your science matters!
Just add students, a new academic year begins! @stanforduniversity.bsky.social
September 16, 2025 at 4:21 PM
Just add students, a new academic year begins! @stanforduniversity.bsky.social
Reposted by Ann Mullally
Happening today at noon! 👇🏽
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
September 11, 2025 at 5:58 PM
Happening today at noon! 👇🏽
Reposted by Ann Mullally
David Baltimore, in his own words (2019).
Sixty Years of Discovery | Annual Reviews
Each of us is a story. Mine is a story of doing science for 60 years, and I am honored to be asked to tell it. Even though this autobiography was written for the Annual Review of Immunology, I have ch...
www.annualreviews.org
September 7, 2025 at 10:05 PM
David Baltimore, in his own words (2019).
Reposted by Ann Mullally
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87
www.nytimes.com
September 7, 2025 at 9:07 PM
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
September 3, 2025 at 4:00 PM
Excited to kick off a new year of Stanford #Hematology Breakthroughs seminars! We start w/ Prof. Lucy Godley from Northwestern Feinberg SOM speaking on germline predisposition to heme malignancies, a topic on which she has immense expertise, promises to be a great seminar, next week! 👇🏽
Reposted by Ann Mullally
Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18
September 2, 2025 at 6:39 PM
Excited to share our discovery of potent TRIM21 molecular glues with anticancer activity, online today @CD_AACR: "Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex". 1/18
Reposted by Ann Mullally
Please check out this thread on our latest paper in
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
Haematopoietic stem cell number is not solely defined by niche availability
Nature - Haematopoietic stem cell numbers are restricted at both systemic and local levels.
rdcu.be
August 28, 2025 at 2:19 AM
Please check out this thread on our latest paper in
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)
@nature.com on HSC pool size regulation. rdcu.be/eCJLe
Phenomenal collaboration with @gritsmanlab.bsky.social, and driven by the outstanding Shoichiro Takeishi! @einsteincellbio.bsky.social
@einsteinmededu.bsky.social (1/6)